日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human clinical trial of plasmapheresis effects on biomarkers of aging (efficacy and safety trial)

血浆置换对衰老生物标志物影响的人体临床试验(疗效和安全性试验)

Borsky, Pavel; Holmannova, Drahomira; Parova, Helena; Horvath, Steve; Sramek, Petr; Brooke, Robert T; Milciute, Milda; Gordevicius, Juozas; Fiala, Zdenek; Andrys, Ctirad; Kremlacek, Jan; Rehacek, Vit; Baranova, Ivana; Matyasovska, Natalia; Borska, Lenka

The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants

银屑病、代谢综合征及其合并症会增加受试者血清中 CRP 和 CD5L 的水平,但不会增加 sCD200R1 和 sTLR2 的水平。

Holmannova, Drahomira; Borsky, Pavel; Andrys, Ctirad; Krejsek, Jan; Cermakova, Eva; Fiala, Zdenek; Hamakova, Kvetoslava; Svadlakova, Tereza; Parova, Helena; Rehacek, Vit; Poctova, Gabriela; Borska, Lenka

Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls.

寻常型银屑病患者的衰老:女性患者的表观遗传年龄比健康对照组要大

Borsky Pavel, Chmelarova Marcela, Fiala Zdenek, Hamakova Kvetoslava, Palicka Vladimir, Krejsek Jan, Andrys Ctirad, Kremlacek Jan, Rehacek Vit, Beranek Martin, Malkova Andrea, Svadlakova Tereza, Holmannova Drahomira, Borska Lenka